The differences between AU565 and SK-BR-3 in AA-induced transcriptional regulation of other antioxidant enzymes, such as SOD and GPX that determine the intensity of lipid peroxidation, could also serve as predictive biomarkers for selecting therapy for Her2-amplified breast cancer. The gene discussed is ERBB2; the disease is breast cancer.